TFS Capital’s NxStage Medical Inc. NXTM Stock Holding History

TFS Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-84,383	Closed	-$1.26M	–	1307
2016 Q1	$1.26M	Buy	84,383 +15,673	+23%	+$263K	0.18%	188
2015 Q4	$1.5M	Sell	68,710 -61,812	-47%	-$1.15M	0.16%	232
2015 Q3	$2.06M	Buy	130,522 +82,178	+170%	+$1.32M	0.2%	153
2015 Q2	$691K	Buy	+48,344	New	+$819K	0.07%	425
2014 Q3	–	Sell	-16,497	Closed	-$237K	–	1324
2014 Q2	$237K	Buy	+16,497	New	+$215K	0.02%	902

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TFS Capital's NXTM Position: Q2 2016 in Review

TFS Capital sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 84,383 shares — an estimated $1.26M sold.

TFS Capital first reported a position in NXTM in Q2 2014 and held it in 5 quarters. The position peaked at $2.06M in Q3 2015. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

TFS Capital reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
TFS Capital sold 84,383 NxStage Medical Inc. shares in Q2 2016, an estimated $1.26M.
TFS Capital first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 5 quarters.
TFS Capital's NxStage Medical Inc. position peaked at $2.06M in Q3 2015.
147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.